Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -116,215 | -82,370 | -56,267 | -29,629 | -101,775 |
| Depreciation Amortization | 4,887 | 3,752 | 2,571 | 1,307 | 9,351 |
| Accounts receivable | 394 | 255 | 239 | -87 | 488 |
| Accounts payable and accrued liabilities | 10,365 | 3,824 | 2,360 | 3,849 | -5,238 |
| Other Working Capital | 10,213 | 2,913 | 1,898 | 3,483 | 1,008 |
| Other Operating Activity | 2,418 | 6,179 | 3,970 | -463 | 13,798 |
| Operating Cash Flow | $-87,938 | $-65,447 | $-45,229 | $-21,540 | $-82,368 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 68,536 | 50,298 | 83,609 | 29,041 | -107,215 |
| PPE Investments | 1,419 | 1,625 | 1,701 | -464 | -1,068 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -5,561 |
| Purchase Of Investment | N/A | N/A | -64,126 | -33,895 | N/A |
| Investing Cash Flow | $69,955 | $51,923 | $21,184 | $-5,318 | $-113,844 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 11,377 |
| Debt Repayment | -3,589 | -3,244 | -2,915 | -284 | -49,858 |
| Common Stock Issued | 160,781 | 189 | 188 | 160 | 181,496 |
| Common Stock Repurchased | -108 | -108 | -108 | -108 | -149 |
| Financing Cash Flow | $157,084 | $-3,163 | $-2,835 | $-232 | $142,866 |
| Beginning Cash Position | 47,208 | 47,208 | 47,208 | 47,208 | 100,554 |
| End Cash Position | 186,309 | 30,521 | 20,328 | 20,118 | 47,208 |
| Net Cash Flow | $139,101 | $-16,687 | $-26,880 | $-27,090 | $-53,346 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,938 | -65,447 | -45,229 | -21,540 | -82,368 |
| Capital Expenditure | -1,206 | -997 | -815 | -507 | -1,132 |
| Free Cash Flow | -89,144 | -66,444 | -46,044 | -22,047 | -83,500 |